TELA TELA Bio
- 5.530
- -0.090-1.60%
TELA Bio News
Analysts Are Bullish on Top Healthcare Stocks: TELA Bio (TELA), Rezolute (RZLT)
Analysts Offer Insights on Healthcare Companies: Evogene (EVGN), TELA Bio (TELA) and InfuSystem Holdings, Inc. (INFU)
Express News | TELA Bio Appoints Greg Firestone as Chief Commercial Officer
TELA Bio, Inc. (NASDAQ:TELA) Q1 2024 Earnings Call Transcript
TELA Bio First Quarter 2024 Earnings: US$0.23 Loss per Share (Vs US$0.63 Loss in 1Q 2023)
TELA Bio | 10-Q: Quarterly report
Express News | TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Express News | TELA Bio Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Revenue Results and Raised Its FY24 Revenue Guidance
TELA Bio Price Target Cut to $10.00/Share From $12.00 by Piper Sandler
TELA Bio Price Target Cut to $10.00/Share From $12.00 by Piper Sandler
Express News | Piper Sandler Reiterates Overweight on TELA Bio, Lowers Price Target to $10
TELA Bio Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/10/2024 97.63% Piper Sandler $12 → $10 Reiterates Overweight → Overweight 03/22/2024 196.44% JMP Securi
TELA Bio's Robust Growth and Promising Outlook Merit Bullish Stance
TELA Bio (TELA) Gets a Buy From Piper Sandler
Express News | TELA Bio Increases FY24 Revenue Guidance From $74M-$76M To $74.5M-$76.5M, Est $74.94M
TELA Bio Q1 2024 Adj EPS $(0.54) Misses $(0.50) Estimate, Sales $16.603M Beat $16.319M Estimate
TELA Bio (NASDAQ:TELA) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimate of $(0.50) by 8 percent. This is a 14.29 percent increase over losses of $(0.63) per s
Express News | TELA Bio Inc - Increased Full Year 2024 Revenue Guidance to $74.5 Million to $76.5 Million
TELA Bio Reveals Strategic Direction in Updated Investor Deck
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersSensus Healthcare (NASDAQ:SRTS) shares increased by 33.3% to $5.08 during Thursday's after-market session. The market value of their outstanding shares is at $83.2 million. As per the news, the
Earnings Flash (TELA) TELA BIO Posts Q1 Revenue $16.6M, Vs. Street Est of $16.3M
04:29 PM EDT, 05/09/2024 (MT Newswires) -- Earnings Flash (TELA) TELA BIO Posts Q1 Revenue $16.6M, vs. Street Est of $16.3M
Express News | TELA Bio Q1 Revenue USD 16.603 Million Vs. Ibes Estimate USD 16.3 Million
Analysis
Price Target
No Data
